The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Timing of somatic next-generation sequencing (NGS) in metastatic prostate cancer.
 
Karen Udoh
No Relationships to Disclose
 
Yasaman Iranmanesh
No Relationships to Disclose
 
Madelyn Klugman
No Relationships to Disclose
 
Hyunsoo Song
No Relationships to Disclose
 
Arya Rasouli
No Relationships to Disclose
 
Alexander Baras
No Relationships to Disclose
 
Laura Sena
Research Funding - Panbela Therapeutics (Inst)
 
Adel Mandl
Employment - EMD Serono (I)
 
Mark Markowski
No Relationships to Disclose
 
Channing Paller
Consulting or Advisory Role - AstraZeneca; Bayer; Dendreon; Exelixis; Janssen Oncology; Omnitura; Pfizer
Research Funding - Lilly (Inst)
Travel, Accommodations, Expenses - Bayer; Bayer; Bayer
 
Samuel Denmeade
Research Funding - Astellas Pharma (Inst); Bayer
 
Otis Brawley
Leadership - Agilent; Illumina; Incyte; Jackson Laboratory for Genomic Medicine; Lyell Immunopharma; PDS Biotechnology
Stock and Other Ownership Interests - Agilent; Incyte
Honoraria - AstraZeneca; Genentech/Roche; Grail
Consulting or Advisory Role - Genentech/Roche; Grail
Travel, Accommodations, Expenses - Genentech/Roche
 
Michael Carducci
Honoraria - Remedica
Consulting or Advisory Role - Acrivon Therapeutics; Amgen; AstraZeneca; Pfizer
 
Emmanuel Antonarakis
Consulting or Advisory Role - AADi; AIkido Pharma; Amgen; AstraZeneca; Bayer (Inst); Blue Earth Diagnostics; Corcept Therapeutics; Curium Pharma; Foundation Medicine; Hookipa Pharma; Janssen Biotech; Lilly; Menarini Silicon Biosystems; Merck; Pfizer; Sanofi; Tango Therapeutics; Tempus; Z-Alpha
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Macrogenics (Inst); Merck (Inst); Orion Health (Inst)
Patents, Royalties, Other Intellectual Property - Co-inventor of a biomarker technology that has been licensed to Qiagen
 
Mario Eisenberger
Stock and Other Ownership Interests - Veru
Honoraria - Bayer; Merck Sharp & Dohme; Seagen
Travel, Accommodations, Expenses - Veru
 
Catherine Marshall
Honoraria - Tempus
Consulting or Advisory Role - Bayer; Dendreon; McGraw-Hill Education; Obseva
Research Funding - AstraZeneca (Inst)
Patents, Royalties, Other Intellectual Property - McGraw Hill - textbook royalties
Travel, Accommodations, Expenses - Bayer